Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Scientists Create Immunity to Deadly Parasite by Manipulating Host's Genes

September 23, 2015 8:15 am | by University of Virginia | News | Comments

There are two common approaches to protecting humans from infectious disease. Read more...


FDA Approves Taiho Oncology's MCRC Drug

September 23, 2015 8:00 am | News | Comments

Lonsurf is intended for the treatment of patients with a form metastatic colorectal cancer (mCRC) that is resistant to other forms of treatment. Read more...


Global HIV Therapeutics Market Value Will Crawl to Almost $15.3B by 2023

September 23, 2015 7:45 am | by Moritz Hermann, Ph.D., Analyst, GlobalData | News | Comments

The market growth will mainly be driven by the introduction of novel drugs, such as STRs with improved tolerability, a reduced pill burden or increased efficacy, and an increasing number of people living with HIV who are treated with antiretroviral therapy (ART). Read more...


Bausch + Lomb, Nicox Announce FDA Acceptance of NDA for Vesneo

September 23, 2015 7:30 am | News | Comments

Vesneo was licensed by Nicox to Bausch + Lomb. Read more...


Increased Chances for Early Detection of Alzheimer's Disease

September 23, 2015 7:15 am | by Lund University | News | Comments

A method for detecting early signs of Alzheimer’s disease using amyloid PET imaging works as well as the previously used cerebrospinal fluid sample method. Read more...


Pfizer says it Could be Leader in Cancer with Many New Drugs

September 23, 2015 7:00 am | by Linda A. Johnson, AP Business Writer | News | Comments

Drug giant Pfizer is starting 20 clinical trials this year and more soon after on treatments to conquer cancer as it also seeks to gain leadership in one of the hottest, and most lucrative, areas of medicine. Read more...


Scientists Identify DNA Alterations as Among Earliest to Occur in Lung Cancer Development

September 22, 2015 12:51 pm | by Johns Hopkins University | News | Comments

Working with tissue, blood and DNA from six people with precancerous and cancerous lung lesions, a team of Johns Hopkins scientists has identified what it believes are among the very earliest “premalignant” genetic changes that mark the potential onset of the most common and deadliest form of disease. Read more...


Researchers to Develop Breathalyzer-type Low Blood Sugar Warning for Diabetes

September 22, 2015 12:38 pm | by Indiana University | News | Comments

A multidisciplinary team of researchers at Indiana University-Purdue University Indianapolis has been awarded a $738,000 National Science Foundation grant to develop a breathalyzer-type device to detect the onset of hypoglycemia, or low blood sugar episodes, in people with diabetes. Read more...


Regeneron: Agreement with BARDA for Development of New Ebola Antibody Treatment

September 22, 2015 12:31 pm | News | Comments

Regeneron Pharmaceuticals, announced an agreement with the Biomedical Advanced Research and Development Authority (BARDA) of the U.S. Department of Health and Human Services (HHS) to develop, test and manufacture a monoclonal antibody therapy for the treatment of Ebola virus infection. Read more...


Roche Introduces Enhanced Whole Exome Sequencing Solution

September 22, 2015 12:28 pm | News | Comments

Roche today announced the global launch of the SeqCap EZ MedExome Target Enrichment Kit, a comprehensive whole exome sequencing (WES) solution designed to increase the discovery and detection of human genetic variants associated with disease while reducing sequencing costs. Read more...


FDA Experts to Review Safety of Essure Birth Control Implant

September 22, 2015 12:20 pm | by Matthew Perrone, AP Health Writer | News | Comments

Federal medical experts will take a closer look at a host of problems reported with the birth control implant called Essure, including chronic pain, bleeding, headaches and allergic reactions. Read more...


Tuberculosis Drug's Big Price Hike is Revoked by Rodelis Therapeutics

September 22, 2015 11:15 am | by Stephanie Guzowski, Editor | News | Comments

A significant price increase for a specialty tuberculosis drug was rescinded Monday after the company that acquired the drug’s rights returned it to its previous owner, following public outrage. Rodelis Therapeutics acquired the rights to cycloserine last month, and raised its price 2,600 percent, from $500 for 30 capsules to $10,800. Read more...


Global HBV Therapeutics Market Value to Grow Slowly to $3.5B by 2021

September 22, 2015 8:31 am | by Priyatham Salimadugu, Analyst, GBI Research | News | Comments

The global late-stage pipeline is weak due to the lack of first-in-class and innovative products in late-stage clinical development. Read more...


Role of Cancer-Suppressing Gene Uncovered

September 22, 2015 8:25 am | by University of Adelaide | News | Comments

Researchers have uncovered the role played by a gene which suppresses the development of cancer. Read more...


Old Drug Performs New Tricks

September 22, 2015 7:45 am | by University of Cambridge | News | Comments

Patients with the most dangerous type of high blood pressure will be able to receive far more effective treatment after Cambridge-led research reveals the powers of a "wonder drug" that has lain under the noses of doctors for 50 years. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.